GoodRx Holdings (GDRX) Price to FCF (2020 - 2026)

GoodRx Holdings has disclosed Price to FCF across 7 years of filings, most recently posting 14.67 for Q2 2026.

• In Q2 2026, Price to FCF fell 73.57% year-over-year to 14.67; the TTM figure through Jun 2026 stood at 7.19 (down 51.28% YoY), while the FY2025 annual figure was 9.49, down 38.81% from the prior year.
• Price to FCF came in at 14.67 for Q2 2026 at GoodRx Holdings, up from 76.31 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 775.44 in Q4 2023 to a low of 406.77 in Q2 2024.
• Average Price to FCF over 5 years is 83.92, with a median of 58.14 recorded in 2025.
• Year-over-year, Price to FCF surged 601.58% in 2023 and sank 382.35% in 2024.
• Over 5 years, Price to FCF stood at 110.53 in 2022, then surged by 601.58% to 775.44 in 2023, then tumbled by 91.88% to 62.99 in 2024, then declined by 19.81% to 50.51 in 2025, then plunged by 70.96% to 14.67 in 2026.
• Per Business Quant data, the three most recent Price to FCF figures were 14.67 in Q2 2026, 76.31 in Q1 2026, and 50.51 in Q4 2025.